Relebactam Monohydrate is a non‑β‑lactam β‑lactamase inhibitor.
It is often used in combination with imipenem/cilastatin to restore antibacterial activity against multidrug‑resistant Gram‑negative strains that produce class A, C, and some class D β‑lactamases.
It is indicated for the treatment of:
Complicated urinary tract infections
Complicated intra‑abdominal infections
Hospital‑acquired and ventilator‑associated bacterial pneumonia
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea